US Stock MarketDetailed Quotes

TBPH Theravance Biopharma

Watchlist
  • 9.120
  • -0.020-0.22%
Close Apr 26 16:00 ET
  • 9.120
  • 0.0000.00%
Post 16:13 ET
442.87MMarket Cap-9120P/E (TTM)

Theravance Biopharma Key Stats

Theravance Biopharma Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Feb 26, 2024

Revenue(YoY)

17.57M

+19.91%
EPS(YoY)

-0.17

-13.33%

Strong Buy

Apr 12, 2024

Theravance Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 16.057M--
--2024/Q1-- / 13.950M--
Feb 26, 20242023/Q417.565M / 17.575M--
Nov 7, 20232023/Q315.693M / 15.052M--
Aug 7, 20232023/Q213.749M / 15.421M--
May 8, 20232023/Q110.417M / 13.703M--
Feb 27, 20232022/Q414.649M / 15.729M--
Nov 7, 20222022/Q312.451M / 11.810M--
Aug 4, 20222022/Q211.050M / 11.803M--
May 5, 20222022/Q113.196M / 14.484M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 16.057M--
--2024/Q1-- / 13.950M--
Feb 26, 20242023/Q417.565M / 17.575M--
Nov 7, 20232023/Q315.693M / 15.052M--
Aug 7, 20232023/Q213.749M / 15.421M--
May 8, 20232023/Q110.417M / 13.703M--
Feb 27, 20232022/Q414.649M / 15.729M--
Nov 7, 20222022/Q312.451M / 11.810M--
Aug 4, 20222022/Q211.050M / 11.803M--
May 5, 20222022/Q113.196M / 14.484M--

Unlock Free Earnings Estimates

Theravance Biopharma Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 12, 2024

Strong Buy

  • Buy

    75.00%
  • Hold

    25.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg